Article
Author(s):
Top stories of the week on Specialty Pharmacy Times.
[<a href="//storify.com/pharmacytimes/ms-drug-cancer-link-rebuffed-highlights-specialty-" target="_blank">View the story "MS Drug Cancer Link Rebuffed Highlights Specialty Pharmacy Week in Review" on Storify</a>]
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa